These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16453095)

  • 21. Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy.
    Corrao G; Zambon A; Parodi A; Poluzzi E; Baldi I; Merlino L; Cesana G; Mancia G
    J Hypertens; 2008 Apr; 26(4):819-24. PubMed ID: 18327094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable].
    Pischon T; Sharma AM
    MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C; Croce G; Desideri G
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-hypertensive drug utilization in Continental Portugal (1999-2004).
    Furtado C; Pinto M
    Rev Port Cardiol; 2006 Mar; 25(3):273-92. PubMed ID: 16789402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism.
    Kudoh T; Nagawaga T; Nakagawa I
    Hypertens Res; 2008 Mar; 31(3):455-62. PubMed ID: 18497464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive drugs and fibrinolytic function.
    Fogari R; Zoppi A
    Am J Hypertens; 2006 Dec; 19(12):1293-9. PubMed ID: 17161777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypertension control in community health centers across China: analysis of antihypertensive drug treatment patterns.
    Wang Z; Wang X; Chen Z; Wang W; Zhu H; Chen W; Zhu M; Hu S; Staessen JA; Liu L; Fodor JG;
    Am J Hypertens; 2014 Feb; 27(2):252-9. PubMed ID: 24108862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive treatment and control in a large primary care population of 21 167 patients.
    Qvarnström M; Wettermark B; Ljungman C; Zarrinkoub R; Hasselström J; Manhem K; Sundström A; Kahan T
    J Hum Hypertens; 2011 Aug; 25(8):484-91. PubMed ID: 20720572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antihypertensive therapy in 357 inpatients of elderly isolated systolic hypertension].
    Zhai LH; Yang CY; Jiang KW; Xu XY; Lu HZ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):719-22, 725. PubMed ID: 16708819
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Success of blood pressure reduction in diabetic patients].
    Schernthaner G
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S247-51. PubMed ID: 17139580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension.
    White WB
    Blood Press Monit; 2008 Apr; 13(2):123-9. PubMed ID: 18347448
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal analysis of antihypertensive drug interactions in a Medicaid population.
    Carter BL; Lund BC; Hayase N; Chrischilles E
    Am J Hypertens; 2004 May; 17(5 Pt 1):421-7. PubMed ID: 15110901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity paradox in patients with hypertension and coronary artery disease.
    Uretsky S; Messerli FH; Bangalore S; Champion A; Cooper-Dehoff RM; Zhou Q; Pepine CJ
    Am J Med; 2007 Oct; 120(10):863-70. PubMed ID: 17904457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine arterial hypertension: therapeutic approach in clinical practice.
    Mazza A; Armigliato M; Zamboni S; Rempelou P; Rubello D; Pessina AC; Casiglia E
    Minerva Endocrinol; 2008 Dec; 33(4):297-312. PubMed ID: 18923367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of the alpha-adducin G460W polymorphism and angiotensinogen M235T polymorphism on antihypertensive medication and blood pressure.
    Schelleman H; Klungel OH; Witteman JC; Hofman A; van Duijn CM; de Boer A; Stricker BH
    Eur J Hum Genet; 2006 Jul; 14(7):860-6. PubMed ID: 16724011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Development of various forms of hypertension and a new assessment of antihypertensive medication].
    Middeke M
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1449-51. PubMed ID: 16794973
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.